SWTX logo

SpringWorks Therapeutics (SWTX) Cash from operations

annual CFO:

-$175.60M+$47.20M(+21.18%)
December 31, 2024

Summary

  • As of today (July 1, 2025), SWTX annual cash flow from operations is -$175.60 million, with the most recent change of +$47.20 million (+21.18%) on December 31, 2024.
  • During the last 3 years, SWTX annual CFO has fallen by -$47.72 million (-37.32%).
  • SWTX annual CFO is now -1139.58% below its all-time high of -$14.17 million, reached on December 31, 2018.

Performance

SWTX Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSWTXcash flow metrics

quarterly CFO:

-$68.76M-$39.26M(-133.08%)
March 31, 2025

Summary

  • As of today (July 1, 2025), SWTX quarterly cash flow from operations is -$68.76 million, with the most recent change of -$39.26 million (-133.08%) on March 31, 2025.
  • Over the past year, SWTX quarterly CFO has increased by +$10.17 million (+12.89%).
  • SWTX quarterly CFO is now -556.39% below its all-time high of $15.07 million, reached on December 31, 2020.

Performance

SWTX quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSWTXcash flow metrics

TTM CFO:

-$165.43M+$10.17M(+5.79%)
March 31, 2025

Summary

  • As of today (July 1, 2025), SWTX TTM cash flow from operations is -$165.43 million, with the most recent change of +$10.17 million (+5.79%) on March 31, 2025.
  • Over the past year, SWTX TTM CFO has increased by +$74.48 million (+31.04%).
  • SWTX TTM CFO is now -2204.97% below its all-time high of -$7.18 million, reached on March 31, 2019.

Performance

SWTX TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSWTXcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

SWTX Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+21.2%+12.9%+31.0%
3 y3 years-37.3%-41.2%-6.4%
5 y5 years-270.1%-319.3%-176.9%

SWTX Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-37.3%+21.2%-250.7%+12.9%-7.7%+31.0%
5 y5-year-445.5%+21.2%-556.4%+12.9%-413.9%+31.0%
alltimeall time-1139.6%+21.2%-556.4%+12.9%-2205.0%+31.0%

SWTX Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
-$68.76M(+133.1%)
-$165.43M(-5.8%)
Dec 2024
-$175.60M(-21.2%)
-$29.50M(+16.2%)
-$175.60M(-15.9%)
Sep 2024
-
-$25.38M(-39.3%)
-$208.80M(-10.7%)
Jun 2024
-
-$41.79M(-47.1%)
-$233.89M(-2.5%)
Mar 2024
-
-$78.93M(+25.9%)
-$239.91M(+7.7%)
Dec 2023
-$222.79M(+37.9%)
-$62.70M(+24.3%)
-$222.79M(+4.0%)
Sep 2023
-
-$50.46M(+5.5%)
-$214.29M(+16.8%)
Jun 2023
-
-$47.81M(-22.7%)
-$183.43M(+5.0%)
Mar 2023
-
-$61.82M(+14.1%)
-$174.69M(+8.1%)
Dec 2022
-$161.56M(+26.3%)
-$54.20M(+176.5%)
-$161.56M(+5.1%)
Sep 2022
-
-$19.60M(-49.8%)
-$153.68M(-4.5%)
Jun 2022
-
-$39.07M(-19.8%)
-$161.00M(+3.6%)
Mar 2022
-
-$48.69M(+5.1%)
-$155.46M(+21.6%)
DateAnnualQuarterlyTTM
Dec 2021
-$127.88M(+297.2%)
-$46.32M(+72.0%)
-$127.88M(+92.3%)
Sep 2021
-
-$26.93M(-19.7%)
-$66.50M(+22.5%)
Jun 2021
-
-$33.53M(+58.9%)
-$54.27M(+47.1%)
Mar 2021
-
-$21.10M(-240.1%)
-$36.90M(+14.6%)
Dec 2020
-$32.19M(-32.1%)
$15.07M(-202.5%)
-$32.19M(-49.2%)
Sep 2020
-
-$14.70M(-9.0%)
-$63.32M(+6.0%)
Jun 2020
-
-$16.16M(-1.5%)
-$59.73M(+5.4%)
Mar 2020
-
-$16.40M(+2.1%)
-$56.66M(+19.4%)
Dec 2019
-$47.44M(+234.9%)
-$16.06M(+44.5%)
-$47.44M(+51.2%)
Sep 2019
-
-$11.11M(-15.1%)
-$31.38M(+54.8%)
Jun 2019
-
-$13.09M(+82.4%)
-$20.27M(+182.4%)
Mar 2019
-
-$7.18M
-$7.18M
Dec 2018
-$14.17M
-
-

FAQ

  • What is SpringWorks Therapeutics annual cash flow from operations?
  • What is the all time high annual CFO for SpringWorks Therapeutics?
  • What is SpringWorks Therapeutics annual CFO year-on-year change?
  • What is SpringWorks Therapeutics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for SpringWorks Therapeutics?
  • What is SpringWorks Therapeutics quarterly CFO year-on-year change?
  • What is SpringWorks Therapeutics TTM cash flow from operations?
  • What is the all time high TTM CFO for SpringWorks Therapeutics?
  • What is SpringWorks Therapeutics TTM CFO year-on-year change?

What is SpringWorks Therapeutics annual cash flow from operations?

The current annual CFO of SWTX is -$175.60M

What is the all time high annual CFO for SpringWorks Therapeutics?

SpringWorks Therapeutics all-time high annual cash flow from operations is -$14.17M

What is SpringWorks Therapeutics annual CFO year-on-year change?

Over the past year, SWTX annual cash flow from operations has changed by +$47.20M (+21.18%)

What is SpringWorks Therapeutics quarterly cash flow from operations?

The current quarterly CFO of SWTX is -$68.76M

What is the all time high quarterly CFO for SpringWorks Therapeutics?

SpringWorks Therapeutics all-time high quarterly cash flow from operations is $15.07M

What is SpringWorks Therapeutics quarterly CFO year-on-year change?

Over the past year, SWTX quarterly cash flow from operations has changed by +$10.17M (+12.89%)

What is SpringWorks Therapeutics TTM cash flow from operations?

The current TTM CFO of SWTX is -$165.43M

What is the all time high TTM CFO for SpringWorks Therapeutics?

SpringWorks Therapeutics all-time high TTM cash flow from operations is -$7.18M

What is SpringWorks Therapeutics TTM CFO year-on-year change?

Over the past year, SWTX TTM cash flow from operations has changed by +$74.48M (+31.04%)
On this page